Explore All Access
Check if your research matches the topics covered in Journal of Immunotherapy?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Journal of Immunotherapy : Impact Factor & More
eISSN: 1537-4513pISSN: 1524-9557
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Journal of Immunotherapy Key Metrics
CiteScore 
7.9
Eigenfactor
0.001 - 0.005
H-Index
103
Impact Factor
< 5
SJR
Q1Immunology
SNIP
0.8
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months11%
4 to 6 months34%
7 to 9 months31%
Above 9 months23%
Did you find this useful?
Topics Covered on Journal of Immunotherapy
Immune checkpoint inhibitors
Odds ratio
Confidence interval
Pembrolizumab
Nivolumab
Autologous tumor
Melanoma
Tumor-infiltrating lymphocytes
Overall survival
Advanced melanoma
Colorectal cancer
Hazard ratio
Ipilimumab
Avelumab
Soft tissue sarcoma
Clinical trial
Attributable risk
Immunotherapy
Journal of Immunotherapy Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Immunotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal of Immunotherapy
Machine Learning-enhanced Signature of Metastasis-related T Cell Marker Genes for Predicting Overall Survival in Malignant Melanoma.
- 7 Nov 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Poly (ADP-Ribose) Polymerase 1 Induces Cyclic GMP-AMP Synthase-stimulator of Interferon Genes Pathway Dysregulation to Promote Immune Escape of Colorectal Cancer Cells
- 22 Oct 2024
- Journal of Immunotherapy
Brief Communication: Combination of an MIP3α-Antigen Fusion Therapeutic DNA Vaccine With Treatments of IFNα and 5-Aza-2'Deoxycytidine Enhances Activated Effector CD8+ T Cells Expressing CD11c in the B16F10 Melanoma Model.
- 14 Oct 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
- 1 Oct 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Vitexin Inhibits TNBC Progression and Metastasis by Modulating Macrophage Polarization Through EGFR Signaling.
- 1 Oct 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Brief Communication on MAGE-A4 and Coexpression of Cancer Testis Antigens in Metastatic Synovial Sarcomas: Considerations for Development of Immunotherapeutics.
- 3 Sep 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Machine Learning-enhanced Signature of Metastasis-related T Cell Marker Genes for Predicting Overall Survival in Malignant Melanoma.
- 7 Nov 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Poly (ADP-Ribose) Polymerase 1 Induces Cyclic GMP-AMP Synthase-stimulator of Interferon Genes Pathway Dysregulation to Promote Immune Escape of Colorectal Cancer Cells
- 22 Oct 2024
- Journal of Immunotherapy
Brief Communication: Combination of an MIP3α-Antigen Fusion Therapeutic DNA Vaccine With Treatments of IFNα and 5-Aza-2'Deoxycytidine Enhances Activated Effector CD8+ T Cells Expressing CD11c in the B16F10 Melanoma Model.
- 14 Oct 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
- 1 Oct 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Vitexin Inhibits TNBC Progression and Metastasis by Modulating Macrophage Polarization Through EGFR Signaling.
- 1 Oct 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Brief Communication on MAGE-A4 and Coexpression of Cancer Testis Antigens in Metastatic Synovial Sarcomas: Considerations for Development of Immunotherapeutics.
- 3 Sep 2024
- Journal of immunotherapy (Hagerstown, Md. : 1997)
Compare Similar Journals with Journal of Immunotherapy
Select Journals to Compare with Journal of Immunotherapy
Total journals - 8
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Journal for ImmunoTherapy of Cancer
Publisher: BMJ PUBLISHING GROUP
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
0 Journals Selected to compare with
Journal of Immunotherapy
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Journal of Immunotherapy
How long has Journal of Immunotherapy been actively publishing? 
Journal of Immunotherapy has been in operation since 1991 till date.
What is the publishing frequency of Journal of Immunotherapy?
Journal of Immunotherapy published with a Monthly frequency.
How many articles did Journal of Immunotherapy publish last year?
In 2023, Journal of Immunotherapy publsihed 51 articles.
What is the eISSN & pISSN for Journal of Immunotherapy?
For Journal of Immunotherapy, eISSN is 1537-4513 and pISSN is 1524-9557.
What is Citescore for Journal of Immunotherapy?
Citescore for Journal of Immunotherapy is 7.9.
What is the H Index for Journal of Immunotherapy ?
H Index for Journal of Immunotherapy is 103.
What is SNIP score for Journal of Immunotherapy?
SNIP score for Journal of Immunotherapy is 0.8.
What is the SJR for Journal of Immunotherapy?
SJR for Journal of Immunotherapy is Q1.
Who is the publisher of Journal of Immunotherapy?
LIPPINCOTT WILLIAMS & WILKINS is the publisher of Journal of Immunotherapy.
